Edition:
United States

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

68.44USD
4:00pm EDT
Change (% chg)

$-1.25 (-1.79%)
Prev Close
$69.69
Open
$69.80
Day's High
$70.03
Day's Low
$68.39
Volume
45,511
Avg. Vol
156,202
52-wk High
$108.62
52-wk Low
$41.45

Select another date:

Thu, May 17 2018

CORRECTED-UPDATE 1-Loxo Oncology's targeted RET drug shows promise in early trial

CHICAGO, May 16 An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday.

BRIEF-Blueprint Medicines Q1 Loss Per Share $1.29

* BLUEPRINT MEDICINES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Blueprint Medicines Q4 Loss Per Share $1.23

* BLUEPRINT MEDICINES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: